® 150 "

: Xolair ® 150 Mg. ?  »
|
-

S.C

Powder And Solvent For Solution For Injection

Allergic Asthma: Xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. Xolair has been shown to decrease the incidence of asthma exacerbations in these patients. Safety and efficacy have not been established in other allergic conditionsChronic Spontaneous Urticaria (CSU): Xolair is indicated as add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to H1 antihistamine treatment

132 61 31124 00

Novartis Pharma Stein Ag, Switzerland

02/2015 - 02/2025

.
, .
.
/
Omalizumab 150 MG/DOSE
Vial glass type i 1 x 6 ML 48

*

*

 

.

 
" !
 

? !
 »
278
,